Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
- 4 May 2011
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Safety
- Vol. 10 (5), 675-685
- https://doi.org/10.1517/14740338.2011.575778
Abstract
There is a growing consensus that cannabis dependence is a substantial and underappreciated problem. The key component responsible for the euphoric effects of cannabis and its dependence potential is δ-9-tetrahydrocannabinol (THC). THC-containing cannabinoid medicines theoretically pose a risk of abuse and dependence. In order to evaluate the potential of Sativex to cause cannabis-like psychoactivity, abuse or dependence relevant data from all published papers have been reviewed along with the integrated safety analysis for Sativex use in multiple sclerosis (MS) patients on file at GW Pharmaceuticals. In clinical trials, intoxication scores have been low and euphoria reported by only 2.2% of patients. Tolerance has not occurred, abrupt withdrawal has not resulted in a formal withdrawal syndrome, and no cases of abuse or diversion have been reported to date. A formal abuse liability study of Sativex in experienced cannabis smokers showed some abuse potential in comparison with placebo at higher doses, but scores were consistently lower than equivalent doses of THC. Evidence to date suggests that abuse or dependence on Sativex is likely to occur in only a very small proportion of recipients.Keywords
This publication has 34 references indexed in Scilit:
- Emerging strategies for exploiting cannabinoid receptor agonists as medicinesBritish Journal of Pharmacology, 2009
- Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependenceInternational Review of Psychiatry, 2009
- Longitudinal correlates of fatigue in multiple sclerosisMultiple Sclerosis Journal, 2008
- The endocannabinoid system as a target for the treatment of cannabis dependenceNeuropharmacology, 2008
- Use of Dronabinol for Cannabis Dependence: Two Case Reports and ReviewThe American Journal on Addictions, 2008
- A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substancesDrug and Alcohol Dependence, 2008
- Marijuana Withdrawal in Humans: Effects of Oral THC or DivalproexNeuropsychopharmacology, 2003
- Abuse Potential of Dronabinol (Marinol®)Journal of Psychoactive Drugs, 1998
- Marihuana ChemistryScience, 1970
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964